175 related articles for article (PubMed ID: 38552135)
1. Systolic and diastolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension and pre-frailty or frailty status.
Zhu J; Yang K; Liu W
J Clin Hypertens (Greenwich); 2024 May; 26(5):514-524. PubMed ID: 38552135
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk.
Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Marx N; Sliwa K; Weber MA; Williams B; Yusuf S
Eur Heart J; 2019 Jul; 40(25):2032-2043. PubMed ID: 30919899
[TBL] [Abstract][Full Text] [Related]
3. Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
Böhm M; Schumacher H; Teo KK; Lonn E; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder R; Weber M; Sliwa K; Williams B; Yusuf S
Eur Heart J; 2018 Sep; 39(33):3105-3114. PubMed ID: 29873709
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.
Li J; Somers VK; Gao X; Chen Z; Ju J; Lin Q; Mohamed EA; Karim S; Xu H; Zhang L
JAMA Netw Open; 2021 Feb; 4(2):e2037554. PubMed ID: 33595663
[TBL] [Abstract][Full Text] [Related]
5. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
[TBL] [Abstract][Full Text] [Related]
6. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults.
Lee H; Yano Y; Cho SMJ; Park JH; Park S; Lloyd-Jones DM; Kim HC
Circulation; 2020 Jun; 141(22):1778-1786. PubMed ID: 32479205
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.
Bergmark BA; Scirica BM; Steg PG; Fanola CL; Gurmu Y; Mosenzon O; Cahn A; Raz I; Bhatt DL;
Eur Heart J; 2018 Jun; 39(24):2255-2262. PubMed ID: 29394350
[TBL] [Abstract][Full Text] [Related]
9. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.
Tajeu GS; Booth JN; Colantonio LD; Gottesman RF; Howard G; Lackland DT; O'Brien EC; Oparil S; Ravenell J; Safford MM; Seals SR; Shimbo D; Shea S; Spruill TM; Tanner RM; Muntner P
Circulation; 2017 Aug; 136(9):798-812. PubMed ID: 28634217
[TBL] [Abstract][Full Text] [Related]
10. Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study.
Itoga NK; Tawfik DS; Montez-Rath ME; Chang TI
J Am Coll Cardiol; 2021 Oct; 78(17):1671-1678. PubMed ID: 34674811
[TBL] [Abstract][Full Text] [Related]
11. Clinical benefit of systolic blood pressure within the target range among patients with or without diabetes mellitus: a propensity score-matched analysis of two randomized clinical trials.
Li C; Chen K; Shi G; Shi R; Wu Z; Yuan X; Watson V; Jiang Z; Mai H; Yang T; Wang D; Chen T
BMC Med; 2022 Jun; 20(1):208. PubMed ID: 35718771
[TBL] [Abstract][Full Text] [Related]
12. Association of long-term time in target range for systolic blood pressure with cardiovascular risk in the elderly: a Chinese veteran cohort study.
Lin Z; Xiao Z; Chen W; Xu W; Huang C; Xie J; Jin M; Wei X; He S; Xie Z; Liao W; Liao Y; Feng W; Chen Y; Bin J
Eur J Prev Cardiol; 2023 Aug; 30(10):969-977. PubMed ID: 36947144
[TBL] [Abstract][Full Text] [Related]
13. Systolic Blood Pressure Time in Target Range and Incident Atrial Fibrillation in Patients With Hypertension: Insights From the SPRINT Trial.
Wang J; Jiang C; Li S; Wang Z; Wang Y; Lai Y; Wang Z; Lv W; Bai Y; Yang Z; Guo Q; Huang L; He L; Guo X; Li S; Liu N; Jiang C; Tang R; Long D; Du X; Sang C; Dong J; Ma C
Hypertension; 2023 Nov; 80(11):2306-2314. PubMed ID: 37589154
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of blood pressure-lowering treatment by the levels of baseline Framingham risk score: A post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
Zhang L; Sun X; Liao L; Zhang S; Zhou H; Zhong X; Zhuang X; Liao X
J Clin Hypertens (Greenwich); 2019 Dec; 21(12):1813-1820. PubMed ID: 31670874
[TBL] [Abstract][Full Text] [Related]
15. Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular Events.
Buckley LF; Baker WL; Van Tassell BW; Cohen JB; Alkhezi O; Bress AP; Dixon DL
Hypertension; 2023 Feb; 80(2):305-313. PubMed ID: 36254738
[TBL] [Abstract][Full Text] [Related]
16. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Sliwa K; Weber MA; Williams B; Yusuf S
Lancet; 2017 Jun; 389(10085):2226-2237. PubMed ID: 28390695
[TBL] [Abstract][Full Text] [Related]
17. Systolic blood pressure levels among adults with hypertension and incident cardiovascular events: the atherosclerosis risk in communities study.
Rodriguez CJ; Swett K; Agarwal SK; Folsom AR; Fox ER; Loehr LR; Ni H; Rosamond WD; Chang PP
JAMA Intern Med; 2014 Aug; 174(8):1252-61. PubMed ID: 24935209
[TBL] [Abstract][Full Text] [Related]
18. Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial).
Khan NA; Rabkin SW; Zhao Y; McAlister FA; Park JE; Guan M; Chan S; Humphries KH
Hypertension; 2018 May; 71(5):840-847. PubMed ID: 29581214
[TBL] [Abstract][Full Text] [Related]
19. Sustained blood pressure control and coronary heart disease, stroke, heart failure, and mortality: An observational analysis of ALLHAT.
Bowling CB; Davis BR; Luciano A; Simpson LM; Sloane R; Pieper CF; Einhorn PT; Oparil S; Muntner P
J Clin Hypertens (Greenwich); 2019 Apr; 21(4):451-459. PubMed ID: 30864748
[TBL] [Abstract][Full Text] [Related]
20. Systolic-diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study.
Tsimploulis A; Sheriff HM; Lam PH; Dooley DJ; Anker MS; Papademetriou V; Fletcher RD; Faselis C; Fonarow GC; Deedwania P; White M; Valentova M; Blackman MR; Banach M; Morgan CJ; Alagiakrishnan K; Allman RM; Aronow WS; Anker SD; Ahmed A
Int J Cardiol; 2017 May; 235():11-16. PubMed ID: 28291625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
